Research

b12 antibody to beat HIV/ AIDS

Possibility of a new HIV vaccine is positive because scientists have found a new and a rare antibody b12. Co-author of a paper published in the Nature on the study of b12, Peter Kwong, of the National Institutes of Health has found. The b12 antibody provides a key to scientists: its behavior will give the scientists a precise roadmap and idea on which to develop potential vaccines that would replicate b12’s actions. Another advantage of b12 and its target protein (which is called HIV gp120): while the HIV virus is known to mutate again and again, the HIV gp120 protein is stable throughout the existing strains of the virus.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Latest News

To Top